chenodeoxycholic acid has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibb, RK; Herzog, TJ; Horowitz, NS; Hua, J; Mutch, DG; Powell, MA | 1 |
| Akerlund, M; Breeze, A; Filipowska, D; Filipowski, T; Kazanowska, W; Lapinjoki, S; Laudanski, T; Morelowska, B | 1 |
1 trial(s) available for chenodeoxycholic acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug.
Topics: Adenocarcinoma; Adrenal Cortex; Chenodeoxycholic Acid; Cystadenocarcinoma; Drug Carriers; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Lipoproteins, LDL; Liver; Ovarian Neoplasms; Prednisolone; Time Factors; Vincristine | 1992 |
1 other study(ies) available for chenodeoxycholic acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Bile Acids and Salts; Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Cholic Acid; Coloring Agents; Deoxycholic Acid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Nucleosomes; Ovarian Neoplasms; Protein Kinase C; Tetrazolium Salts; Thiazoles; Ursodeoxycholic Acid | 2007 |